Status:
WITHDRAWN
Mixed Chimeric Transplantation for Primary Amyloidosis
Lead Sponsor:
Stanford University
Conditions:
Amyloidosis
Eligibility:
All Genders
Up to 60 years
Phase:
NA
Brief Summary
To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.
Eligibility Criteria
Inclusion
- primary amyloidosis
- adequate organ function
- matched sibling donor
Exclusion
- evidence of multiple myeloma
- HIV positive
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00186095
Start Date
December 1 2000
End Date
September 1 2006
Last Update
June 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.